Literature DB >> 15214205

Barriers to the construction of a valued social identity: a case study of Alzheimer's disease.

Steven R Sabat1, Lisa Napolitano, Heather Fath.   

Abstract

This case study describes a person with mild-to-moderate stage Alzheimer's disease (AD) and examines the relationship between malignant positioning and the ability of a person with AD to gain the cooperation of healthy persons to construct a valued social identity. Findings reveal that malignant positioning limited the person with AD to the embarrassing social identity of dysfunctional patient; whereas, the absence of such positioning allowed the subject to gain the cooperation from others necessary to construct a valued social identity, as well as reduce embarrassment and experience greater sense of self-worth. Preliminary recommendations on reducing malignant positioning are provided. Further research is required to elucidate the degree to which the present findings may be generalized.

Entities:  

Mesh:

Year:  2004        PMID: 15214205     DOI: 10.1177/153331750401900311

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  4 in total

1.  Identity cues and dementia in nursing home intervention.

Authors:  Aline Vézina; Line Robichaud; Philippe Voyer; Daniel Pelletier
Journal:  Work       Date:  2011

2.  Dualities of dementia illness narratives and their role in a narrative economy.

Authors:  Alexandra Hillman; Ian Rees Jones; Catherine Quinn; Sharon M Nelis; Linda Clare
Journal:  Sociol Health Illn       Date:  2018-04-16

Review 3.  Reconsidering frameworks of Alzheimer's dementia when assessing psychosocial outcomes.

Authors:  Joseph E Gaugler; Lisa J Bain; Lauren Mitchell; Jessica Finlay; Sam Fazio; Eric Jutkowitz
Journal:  Alzheimers Dement (N Y)       Date:  2019-08-17

4.  Experiences of dementia in a foreign country: qualitative content analysis of interviews with people with dementia.

Authors:  Monir Mazaheri; Lars E Eriksson; Alireza Nikbakht Nasrabadi; Helena Sunvisson; Kristiina Heikkilä
Journal:  BMC Public Health       Date:  2014-08-04       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.